HEADER HYDROLASE 29-JUN-16 5KO3 TITLE STRUCTURE OF A CORE PAPAIN-LIKE PROTEASE OF MERS CORONAVIRUS WITH TITLE 2 UTILITY FOR STRUCTURE-BASED DRUG DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PEPTIDASE C16 RESIDUES 1544-1800; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 3 ORGANISM_TAXID: 1335626; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MERS PLPRO, SUBSTRATE-BINDING LOOP, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.CLASMAN,Y.M.BAEZ-SANTOS,A.D.MESECAR REVDAT 4 27-SEP-23 5KO3 1 REMARK REVDAT 3 04-DEC-19 5KO3 1 REMARK REVDAT 2 20-SEP-17 5KO3 1 REMARK REVDAT 1 25-JAN-17 5KO3 0 JRNL AUTH J.R.CLASMAN,Y.M.BAEZ-SANTOS,R.C.METTELMAN,A.O'BRIEN, JRNL AUTH 2 S.C.BAKER,A.D.MESECAR JRNL TITL X-RAY STRUCTURE AND ENZYMATIC ACTIVITY PROFILE OF A CORE JRNL TITL 2 PAPAIN-LIKE PROTEASE OF MERS CORONAVIRUS WITH UTILITY FOR JRNL TITL 3 STRUCTURE-BASED DRUG DESIGN. JRNL REF SCI REP V. 7 40292 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 28079137 JRNL DOI 10.1038/SREP40292 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 29042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1470 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2154 - 4.1969 0.98 2931 127 0.1614 0.1783 REMARK 3 2 4.1969 - 3.3316 0.99 2784 170 0.1503 0.1674 REMARK 3 3 3.3316 - 2.9106 0.99 2807 147 0.1739 0.1963 REMARK 3 4 2.9106 - 2.6445 0.99 2730 186 0.1698 0.1912 REMARK 3 5 2.6445 - 2.4550 0.99 2776 141 0.1777 0.2260 REMARK 3 6 2.4550 - 2.3103 0.99 2744 137 0.1686 0.1901 REMARK 3 7 2.3103 - 2.1946 0.99 2740 125 0.1666 0.1865 REMARK 3 8 2.1946 - 2.0990 0.99 2746 147 0.1722 0.2188 REMARK 3 9 2.0990 - 2.0182 0.98 2708 138 0.1985 0.2079 REMARK 3 10 2.0182 - 1.9486 0.95 2606 152 0.2059 0.2339 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 2140 REMARK 3 ANGLE : 1.284 2899 REMARK 3 CHIRALITY : 0.069 326 REMARK 3 PLANARITY : 0.006 367 REMARK 3 DIHEDRAL : 13.503 759 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222508. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29405 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.949 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4P16 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 8.5, 5.5 M AMMONIUM REMARK 280 ACETATE, VAPOR DIFFUSION, SITTING DROP, 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 595 O HOH A 598 2.15 REMARK 500 O HOH A 585 O HOH A 603 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 107 137.81 -170.41 REMARK 500 CYS A 180 47.65 -92.24 REMARK 500 CYS A 181 169.56 176.33 REMARK 500 CYS A 226 -116.79 -75.77 REMARK 500 GLN A 227 -41.75 -142.14 REMARK 500 ALA A 260 79.11 56.12 REMARK 500 ASP A 293 79.88 -107.36 REMARK 500 THR A 308 -74.63 -116.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 191 SG REMARK 620 2 CYS A 194 SG 112.6 REMARK 620 3 CYS A 226 SG 111.3 106.4 REMARK 620 4 CYS A 228 SG 106.2 109.1 111.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 408 DBREF1 5KO3 A 63 319 UNP A0A023J538_9BETC DBREF2 5KO3 A A0A023J538 1544 1800 SEQADV 5KO3 GLY A 92 UNP A0A023J53 GLU 1573 CONFLICT SEQADV 5KO3 LEU A 236 UNP A0A023J53 ILE 1717 CONFLICT SEQRES 1 A 257 ASP GLU THR LYS ALA LEU LYS GLU LEU TYR GLY PRO VAL SEQRES 2 A 257 ASP PRO THR PHE LEU HIS ARG PHE TYR SER LEU LYS ALA SEQRES 3 A 257 ALA VAL HIS GLY TRP LYS MET VAL VAL CYS ASP LYS VAL SEQRES 4 A 257 ARG SER LEU LYS LEU SER ASP ASN ASN CME TYR LEU ASN SEQRES 5 A 257 ALA VAL ILE MET THR LEU ASP LEU LEU LYS ASP ILE LYS SEQRES 6 A 257 PHE VAL ILE PRO ALA LEU GLN HIS ALA PHE MET LYS HIS SEQRES 7 A 257 LYS GLY GLY ASP SER THR ASP PHE ILE ALA LEU ILE MET SEQRES 8 A 257 ALA TYR GLY ASN CYS THR PHE GLY ALA PRO ASP ASP ALA SEQRES 9 A 257 SER ARG LEU LEU HIS THR VAL LEU ALA LYS ALA GLU LEU SEQRES 10 A 257 CYS CYS SER ALA ARG MET VAL TRP ARG GLU TRP CYS ASN SEQRES 11 A 257 VAL CYS GLY ILE LYS ASP VAL VAL LEU GLN GLY LEU LYS SEQRES 12 A 257 ALA CYS CYS TYR VAL GLY VAL GLN THR VAL GLU ASP LEU SEQRES 13 A 257 ARG ALA ARG MET THR TYR VAL CYS GLN CYS GLY GLY GLU SEQRES 14 A 257 ARG HIS ARG GLN LEU VAL GLU HIS THR THR PRO TRP LEU SEQRES 15 A 257 LEU LEU SER GLY THR PRO ASN GLU LYS LEU VAL THR THR SEQRES 16 A 257 SER THR ALA PRO ASP PHE VAL ALA PHE ASN VAL PHE GLN SEQRES 17 A 257 GLY ILE GLU THR ALA VAL GLY HIS TYR VAL HIS ALA ARG SEQRES 18 A 257 LEU LYS GLY GLY LEU ILE LEU LYS PHE ASP SER GLY THR SEQRES 19 A 257 VAL SER LYS THR SER ASP TRP LYS CYS LYS VAL THR ASP SEQRES 20 A 257 VAL LEU PHE PRO GLY GLN LYS TYR SER SER MODRES 5KO3 CME A 111 CYS MODIFIED RESIDUE HET CME A 111 10 HET ZN A 401 1 HET ACT A 402 4 HET ACT A 403 4 HET ACT A 404 7 HET ACT A 405 7 HET ACT A 406 7 HET ACT A 407 7 HET ACT A 408 7 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ZN ZINC ION HETNAM ACT ACETATE ION FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 ZN ZN 2+ FORMUL 3 ACT 7(C2 H3 O2 1-) FORMUL 10 HOH *103(H2 O) HELIX 1 AA1 ASP A 63 GLY A 73 1 11 HELIX 2 AA2 THR A 78 VAL A 90 1 13 HELIX 3 AA3 HIS A 91 TRP A 93 5 3 HELIX 4 AA4 ASN A 110 ASP A 121 1 12 HELIX 5 AA5 ILE A 130 GLY A 142 1 13 HELIX 6 AA6 SER A 145 GLY A 156 1 12 HELIX 7 AA7 ASP A 165 ALA A 175 1 11 HELIX 8 AA8 LEU A 204 ALA A 206 5 3 HELIX 9 AA9 THR A 214 ALA A 220 1 7 SHEET 1 AA1 2 MET A 95 CYS A 98 0 SHEET 2 AA1 2 VAL A 101 LEU A 104 -1 O VAL A 101 N CYS A 98 SHEET 1 AA2 2 ILE A 126 PHE A 128 0 SHEET 2 AA2 2 ALA A 177 LEU A 179 -1 O GLU A 178 N LYS A 127 SHEET 1 AA3 4 GLY A 195 GLN A 202 0 SHEET 2 AA3 4 ARG A 184 CYS A 191 -1 N TRP A 187 O VAL A 199 SHEET 3 AA3 4 GLU A 231 THR A 240 -1 O GLN A 235 N ARG A 188 SHEET 4 AA3 4 MET A 222 VAL A 225 -1 N MET A 222 O ARG A 234 SHEET 1 AA4 4 GLY A 195 GLN A 202 0 SHEET 2 AA4 4 ARG A 184 CYS A 191 -1 N TRP A 187 O VAL A 199 SHEET 3 AA4 4 GLU A 231 THR A 240 -1 O GLN A 235 N ARG A 188 SHEET 4 AA4 4 LYS A 316 SER A 318 -1 O TYR A 317 N HIS A 239 SHEET 1 AA5 7 CYS A 208 VAL A 210 0 SHEET 2 AA5 7 TRP A 243 THR A 256 1 O LEU A 245 N TYR A 209 SHEET 3 AA5 7 ASP A 302 PRO A 313 -1 O VAL A 310 N LEU A 246 SHEET 4 AA5 7 ALA A 265 GLN A 270 -1 N ALA A 265 O LEU A 311 SHEET 5 AA5 7 HIS A 278 LYS A 285 -1 O HIS A 278 N GLN A 270 SHEET 6 AA5 7 LEU A 288 ASP A 293 -1 O PHE A 292 N HIS A 281 SHEET 7 AA5 7 THR A 296 THR A 300 -1 O SER A 298 N LYS A 291 LINK C ASN A 110 N CME A 111 1555 1555 1.34 LINK C CME A 111 N TYR A 112 1555 1555 1.33 LINK SG CYS A 191 ZN ZN A 401 1555 1555 2.65 LINK SG CYS A 194 ZN ZN A 401 1555 1555 2.42 LINK SG CYS A 226 ZN ZN A 401 1555 1555 2.42 LINK SG CYS A 228 ZN ZN A 401 1555 1555 2.53 SITE 1 AC1 4 CYS A 191 CYS A 194 CYS A 226 CYS A 228 SITE 1 AC2 3 TYR A 84 LYS A 87 ACT A 405 SITE 1 AC3 4 VAL A 101 ARG A 283 LYS A 285 HOH A 509 SITE 1 AC4 2 LYS A 299 HOH A 586 SITE 1 AC5 5 ALA A 132 HIS A 135 LYS A 139 ASP A 147 SITE 2 AC5 5 ACT A 402 SITE 1 AC6 3 GLN A 270 LYS A 291 ASP A 293 SITE 1 AC7 6 LYS A 124 ASP A 125 ILE A 126 VAL A 276 SITE 2 AC7 6 HOH A 519 HOH A 522 SITE 1 AC8 5 VAL A 75 ASP A 76 ARG A 82 ALA A 154 SITE 2 AC8 5 ASN A 157 CRYST1 83.705 30.549 86.717 90.00 116.25 90.00 P 1 2 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011947 0.000000 0.005891 0.00000 SCALE2 0.000000 0.032734 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012858 0.00000